Clinical trial

Pressure Assessment to Improve Outcomes After TAVR: a Registry

NCT03923530

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Eplerenone Normalized identity: eplerenoneView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pressure Assessment to Improve Outcomes After TAVR: a Registry

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-06-03

PhaseEARLY_PHASE1

Conditions

Hypertensionunresolved

Aortic Stenosis, Calcificunresolved

Quality of Lifeunresolved

Heart Failure With Preserved Ejection Fractionunresolved

Interventions

EplerenoneDRUG · verified · RxNorm: eplerenone

Sponsors & collaborators

North Florida Foundation for Research and Educationlead sponsor

Malcom Randall VA Medical Centercollaborator

Mapped research locations

GainesvilleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03923530 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.